• Nenhum resultado encontrado

Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis.

N/A
N/A
Protected

Academic year: 2017

Share "Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis."

Copied!
6
0
0

Texto

Loading

Imagem

Figure 1. Flow chart of selection of studies and specific reasons for exclusion from the meta-analysis.
Table 3. Pooled odds ratio for rs198977 in meta-analyses.
Figure 2. Forest plots of studies with Caucasian samples under dominant model (a) and Allele comparison model (b).

Referências

Documentos relacionados

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta- analysis.. Cancer

Despite these limitations, this meta-analysis suggests that the T174M polymorphism of the angiotensinogen gene is not associated with susceptibility of essential hyperten- sion, and

The results showed that the ADAM33 rs2280091 polymorphism in all four genetic models was associated with an increased risk of childhood asthma.. This meta-analysis suggested that

To determine the potential usefulness of KLK2 and KLK3 as biomarkers in the diagnosis of prostate cancer we used multiplex semi-quantitative RT-PCR to detect mRNA in prostate

In conclusion, our results demonstrated an association of the T allele for the LRP5 4037 C>T polymorphism with T1DM susceptibility in a Brazilian population, moreover

We also determined the critical strain rate (CSR), understood as the tangent of the inclination angle between the tangent to the crack development curve and the crack development

Recently, a case-control study found that the IL-22 -429 C/T gene polymorphism might be associated with the risk and multifocality of papillary thyroid cancer (26).. In 561 colon

42 The presentation concluded that ADT is associated with an increased risk of CV events; however, the GnRH antagonist degarelix may be a promising drug, ofering increased